Related Experiment Video

Updated: Jul 2, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Trichosanthin suppresses HeLa cell proliferation through inhibition of the PKC/MAPK signaling pathway

Ping Wang1, Li-Li Chen, Hui Yan

  • 1Institute of Cell Biology, Zhejiang University, Hangzhou, China.

Cell Biology and Toxicology
|August 30, 2008
PubMed

Insights

Trichosanthin (TCS) inhibits HeLa cell proliferation by suppressing protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) signaling pathways. This study elucidates the specific molecular mechanisms underlying TCS

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Trichosanthin (TCS) exhibits anti-tumor properties, notably inhibiting HeLa cell proliferation via apoptosis.
  • The cAMP response element binding (CREB) protein is crucial in apoptotic HeLa cells.
  • Signaling pathways mediating TCS-induced proliferation inhibition remain largely uncharacterized.

Purpose of the Study:

  • To investigate the specific signaling pathways involved in Trichosanthin-induced inhibition of HeLa cell proliferation.
  • To determine the roles of Protein Kinase A (PKA), Protein Kinase C (PKC), and Mitogen-Activated Protein Kinases (MAPKs) in TCS's anti-proliferative effects.

Main Methods:

  • Treatment of HeLa cells with TCS, PKA/PKC inhibitors/activators, and cAMP agonists.
  • Assessment of cell proliferation rates.
  • Analysis of kinase activities and CREB phosphorylation levels.

Main Results:

  • TCS significantly inhibited both PKA and PKC activities.
  • PKC modulation, but not PKA modulation, affected TCS's inhibitory impact on cell proliferation.
  • PKC, ERK1/2, and p38 MAPK blockade partially reversed the effects of cAMP agonists on cell proliferation and CREB phosphorylation.

Conclusions:

  • TCS inhibits HeLa cell proliferation primarily through the suppression of the PKC/MAPK signaling pathway.
  • PKA is not the primary mediator of TCS's anti-proliferative effects in HeLa cells.
  • The findings provide a deeper understanding of the molecular mechanisms of Trichosanthin as an anti-cancer agent.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...